InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.110
-0.130 (-5.80%)
At close: Jul 6, 2026, 4:00 PM EDT
2.120
+0.010 (0.45%)
After-hours: Jul 6, 2026, 7:37 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $310.79 million as of July 6, 2026. Its market cap has increased by 474.87% in one year.
Market Cap
310.79M
Enterprise Value
265.85M
1-Year Change
474.87%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $310.79M, a decrease of -11.55%. That is a compound annual growth rate of -1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 310.79M | 354.20% |
| Dec 31, 2025 | 68.42M | -52.95% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 344.30M |
| Indaptus Therapeutics | 343.12M |
| Fate Therapeutics | 340.35M |
| Larimar Therapeutics | 340.29M |
| Inhibikase Therapeutics | 339.14M |
| Lineage Cell Therapeutics | 336.55M |
| Immuneering | 335.78M |
| Lyell Immunopharma | 327.84M |